Wells Fargo’s Medicines Co MDCO Stock Holding History

Wells Fargo’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-11,700	Closed	-$12K	–	6576
2017 Q2	$12K	Buy	+11,700	New	+$521K	﹤0.01%	5745
2016 Q4	–	Sell	-54,000	Closed	-$195K	–	6562
2016 Q3	$195K	Sell	54,000 -23,000	-30%	-$867K	﹤0.01%	4503
2016 Q2	$13K	Buy	+77,000	New	+$2.71M	﹤0.01%	5612

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Wells Fargo's MDCO Position: Q1 2020 in Review

Wells Fargo sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 1,301,226 shares — an estimated $111M sold.

Wells Fargo first reported a position in MDCO in Q2 2013 and held it in 27 quarters. The position peaked at $111M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

Wells Fargo reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
Wells Fargo sold 1,301,226 Medicines Co shares in Q1 2020, an estimated $111M.
Wells Fargo first reported a position in Medicines Co in Q2 2013 and held it in 27 quarters.
Wells Fargo's Medicines Co position peaked at $111M in Q4 2019.
1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Wells Fargo's 13F filing for Q1 2020, filed 14 May 2020.